HOME › DRUGS › CENOBAMATE
ACTIVE SUBSTANCE / INN

CENOBAMATE

Brand name(s): CENOBAMATE, Ontozry, XCOPRI
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NONE (TENTATIVE APPROVAL)
NDA212839
Epilepsy
ACTIVE SUBSTANCE
Cenobamate
REGULATORS
FDA · EMA
SPONSORS / MAH
ZENARA PHARMA PRIVATE LTD, Angelini Pharma S.p.A, SK LIFE
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
XCOPRINDA212839SK LIFEPrescription
CENOBAMATEANDA219403ZENARA PHARMA PRIVATE LTDNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OntozryAngelini Pharma S.p.AAuthorised26/03/2021Epilepsy

FULL INTELLIGENCE ON CENOBAMATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →